Drug for fatty liver disease in advanced studies
Galmed Pharmaceuticals in Israel is developing a medication to treat NASH, a severe form of fatter liver disease affecting 10 percent of the Western population.
Galmed Pharmaceuticals in Israel is developing a medication to treat NASH, a severe form of fatter liver disease affecting 10 percent of the Western population.